Skip to content
Open access · CC-BY via OpenAlex

Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease

Joanna Agata Motyl, Joanna Benigna Strosznajder, Agnieszka Wencel, Robert Piotr Strosznajder

International Journal of Molecular Sciences · 2021 · ▲ 26 citations

Abstract

Molecular studies have provided increasing evidence that Parkinson's disease (PD) is a protein conformational disease, where the spread of alpha-synuclein (ASN) pathology along the neuraxis correlates with clinical disease outcome. Pathogenic forms of ASN evoke oxidative stress (OS), neuroinflammation, and protein alterations in neighboring cells, thereby intensifying ASN toxicity, neurodegeneration, and neuronal death. A number of evidence suggest that homeostasis between bioactive sphingolipids with opposing function-e.g., sphingosine-1-phosphate (S1P) and ceramide-is essential in pro-survival signaling and cell defense against OS. In contrast, imbalance of the "sphingolipid biostat" favoring pro-oxidative/pro-apoptotic ceramide-mediated changes have been indicated in PD and other neurodegenerative disorders. Therefore, we focused on the role of sphingolipid alterations in ASN burden, as well as in a vast range of its neurotoxic effects. Sphingolipid homeostasis is principally directed by sphingosine kinases (SphKs), which synthesize S1P-a potent lipid mediator regulating cell fate and inflammatory response-making SphK/S1P signaling an essential pharmacological target. A growing number of studies have shown that S1P receptor modulators, and agonists are promising protectants in several neurological diseases. This review demonstrates the relationship between ASN toxicity and alteration of SphK-dependent S1P signaling in OS, neuroinflammation, and neuronal death. Moreover, we discuss the S1P receptor-mediated pathways as a novel promising therapeutic approach in PD.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/ijms22126277
Canonical
link ↗
Fetched
2026-10-27 MST

Cite this

APA
Motyl, J.A., Strosznajder, J.B., Wencel, A., &amp; Strosznajder, R.P. (2021). Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms22126277
Vancouver
Motyl JA, Strosznajder JB, Wencel A, Strosznajder RP. Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease. International Journal of Molecular Sciences. 2021. doi:10.3390/ijms22126277.
BibTeX
@article{joanna2021Recent, title = {Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease}, author = {Joanna Agata Motyl and Joanna Benigna Strosznajder and Agnieszka Wencel and Robert Piotr Strosznajder}, journal = {International Journal of Molecular Sciences}, year = {2021}, doi = {10.3390/ijms22126277}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings